ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

This article reviews the quantitative evidence on the behavioural effects of copayment within
the health area across a wide range of countries. The review distinguishes itself from …

We study the relationship between regulatory regimes and pharmaceutical firms' pricing
strategies using a unique policy experiment in Norway, which in 2003 introduced a …

As pharmaceutical expenditure continues to rise, third-party payers in most high-income
countries have increasingly shifted the burden of payment for prescription drugs to patients …

Background: With the exception of Canada, all countries with universal health insurance
systems provide universal coverage of prescription drugs. Progress toward universal public …

Good health is a determinant of economic growth and a component of the well-being of the
population. This chapter discusses and synthesizes economic models of individual and …

Background—Effective therapies for the secondary prevention of coronary heart disease–
related events are significantly underused, and attempts to improve adherence have often …

This paper examines the causal effect of retirement on health and healthcare utilization
using two identification strategies on Danish full population data. First, I use a reform of the …

We investigate price sensitivity of demand for prescription drugs, using drug purchase
records for the entire Danish population. We identify price responsiveness by exploiting …

The current financial crisis has seen severe austerity measures imposed on the Spanish
health care system, including reduced public spending, copayments, salary reductions, and …